Mitsubishi UFJ Asset Management
ABUS icon

Mitsubishi UFJ Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$237K Sell
52,762
-1,304
-2% -$5.7K ﹤0.01% 949
2025
Q4 		$258K Sell
54,066
-19,624
-27% -$88.2K ﹤0.01% 978
2025
Q3 		$335K Buy
73,690
+147
+0.2% +$540 ﹤0.01% 928
2025
Q2 		$227K Sell
73,543
-2,488
-3% -$8.26K ﹤0.01% 964
2025
Q1 		$265K Buy
76,031
+6,371
+9% +$21.2K ﹤0.01% 921
2024
Q4 		$238K Sell
69,660
-12,287
-15% -$45.2K ﹤0.01% 968
2024
Q3 		$315K Sell
81,947
-7,748
-9% -$29.7K ﹤0.01% 912
2024
Q2 		$277K Buy
+89,695
New +$269K ﹤0.01% 925

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $329M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return